Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 72888-032

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 72888-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg Tablet Bottle Label (NDC 72888-031-01)

Label for Oxybutynin Chloride Extended-Release Tablets USP 10 mg, oral tablet form, distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label includes dosage instructions, storage conditions, and child-resistance warnings. The package contains 100 tablets.*

FDA Label Image

15 mg Tablet Bottle Label (NDC 72888-032-01)

Label for Oxybutynin Chloride Extended-Release Tablets USP 15 mg, oral dosage form, distributed by Advagen Pharma Limited. The label indicates a package size of 100 tablets, Rx only. It includes storage instructions, dosage directions to see package insert, and manufacturer details (Rubicon Research Private Limited, India). The NDC is 72888-032-01.*

FDA Label Image

5 mg Tablet Bottle Label (NDC 72888-030-01)

This label panel for Oxybutynin Chloride Extended-Release Tablets USP 5 mg provides active ingredient information, dosage form, and strength. It includes storage instructions, cautions about moisture and humidity, a child safety warning, manufacturer and distributor details, barcodes, and package size of 100 tablets. The label notes Rx-only status and manufacturing license number.*

FDA Label Image

Figure 1 (Oxybutynin Chloride Er Tab Usp Fig 1)

A line graph comparing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours between Oxybutynin extended release (ER) 10 mg once daily (QD) and Oxybutynin 5 mg three times daily (TID). The x-axis represents time in hours, and the y-axis shows mean plasma concentration with error bars indicating variability.*

FDA Label Image

Figure 2 (Oxybutynin Chloride Er Tab Usp Fig 2)

A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours), with data points at 0, 5, 10, and 24 hours. The y-axis ranges from 0 to 2 ng/mL, displaying plasma concentration values around 0.5 to 0.7 ng/mL with accompanying error bars.*

FDA Label Image

Figure 3 (Oxybutynin Chloride Er Tab Usp Fig 3)

A horizontal plot showing comparative data points for Oxybutynin ER and Placebo, each with error bars. The x-axis ranges from -40 to 40, and both data points fall between -20 and 0 on this scale, indicating a graphical comparison likely related to treatment effect or measurement.*

FDA Label Image

Figure 4 (Oxybutynin Chloride Er Tab Usp Fig 4)

A horizontal bar graph comparing 'Oxybutynin ER' and 'oxybuthynin' values along an x-axis ranging from 40 to 40 with a reference vertical line at zero. Each bar extends leftward from approximately -10 to -22 and -20, respectively, indicating measured data points for oxybutynin forms.*

FDA Label Image

Figure 5 (Oxybutynin Chloride Er Tab Usp Fig 5)

A chart comparing Oxybutynin ER (extended release) and oxybutynin, displayed with data points and error bars across a horizontal axis ranging from -40 to 40. The chart shows relative values centered around negative to positive values with specific positioning for Oxybutynin ER and oxybutynin.*

FDA Label Image

Chemical Structure (Oxybutynin Chloride Er Tab Usp Structure)

Chemical structure of oxybutynin chloride, showing its molecular configuration including a cyclohexyl group, phenyl ring, ester linkage, and a diethylamino group with associated hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.